GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Net Income (Continuing Operations)

Biotech Growth Trust (The) (LSE:BIOG) Net Income (Continuing Operations) : £96.45 Mil (TTM As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Biotech Growth Trust (The) Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Biotech Growth Trust (The)'s Net Income (Continuing Operations) for the six months ended in Sep. 2024 was £8.11 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 was £96.45 Mil.

Biotech Growth Trust (The) Net Income (Continuing Operations) Historical Data

The historical data trend for Biotech Growth Trust (The)'s Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Growth Trust (The) Net Income (Continuing Operations) Chart

Biotech Growth Trust (The) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.90 200.43 -202.42 -41.30 74.60

Biotech Growth Trust (The) Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.99 -78.29 -13.74 88.34 8.11

Biotech Growth Trust (The) Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £96.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotech Growth Trust (The)  (LSE:BIOG) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Biotech Growth Trust (The) Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Biotech Growth Trust (The)'s Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotech Growth Trust (The) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Net Income (Continuing Operations)
Comparable Companies
LSE:BIPS LSE:NAVF LSE:AIE LSE:JAGI LSE:CTUK LSE:MTW LSE:SST LSE:HINT LSE:HNE LSE:BRK BLK BX KKR OSTO:INVE A TSX:BN APO BK AMP XSWX:PGHN OSTO:EQT
Traded in Other Exchanges
BIOGl:UK
Address
25 Southampton Buildings, London, GBR, WC2A 1AL
Website
https://www.biotechgt.com
Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. Its performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Biotech Growth Trust (The) Headlines

No Headlines